Tanya Lewis - Chief Dev. Op. Officer at Replimune Group, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Dev. Op. Officer
Stock Symbol
REPL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Tanya Lewis since 7/7/2023

Holdings reported by Tanya Lewis for Replimune Group, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 135,293 $1.48 M $10.92 Jun 13, 2023 Direct
Employee Stock Option (right to buy) 60,000 Apr 1, 2023 Direct Common Stock

Transactions reported by Tanya Lewis for Replimune Group, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership